about
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsEffect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsEvidence for the prevention and treatment of stroke in dialysis patientsEvaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular diseaseCoronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and womenThe challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women's Heart and Health Study and the British Regional Heart StudyEffect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trialsLack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapyEfficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study.Ensuring trial validity by data quality assurance and diversification of monitoring methods.Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.Analyses of cancer data from three ezetimibe trials.The prevalence of chronic diseases and major disease risk factors at different ages among 150,000 men and women living in Mexico City: cross-sectional analyses of a prospective studyThe effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)Effects of lowering LDL cholesterol on progression of kidney disease.Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysisThe effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort studyBlood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial.What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' CollaboratSerum free light chains and the risk of ESRD and death in CKDImpact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.Cohort profile: the Mexico City Prospective Study.Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study.Stratification for exploring heterogeneity in systematic reviews.Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials.A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache.Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.Early experiences and their relationship to maternal eating disorder symptoms, both lifetime and during pregnancy.Biochemical measures in a population-based study: effect of fasting duration and time of day.Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional HeThe number needed to treat (NNT) can be adjusted for bias when the outcome is measured with error.
P50
Q24619410-8E8D64B3-0FC6-41C1-AFF2-F9291CD93368Q24681288-559CECEF-28B2-49C0-B955-87DE56EEAC31Q26823902-1C45A98F-65CC-4453-B69C-E3E335E31867Q27023274-8C2DCF9D-0331-411D-9A86-61578DBC5E16Q28167988-1CF6B1DD-8C4D-45C6-BDFB-2699D2083268Q28210662-B7A9F82A-7D1B-42A9-A0A3-B06944AE0375Q28212946-17DD21F2-9E61-426E-9224-E6C852CFADE4Q28483807-A075D83E-97BB-4711-888F-0AF781CB616BQ28732707-81633074-5A71-4C18-8112-B81B3191F5E7Q30884055-57F9CA75-47C4-40DE-BD51-99116A7AB67DQ30906124-046E06DF-8B80-43B8-8609-0E443E624D99Q31147048-08B7A13D-27F1-4424-808F-A95148D45A07Q32068104-14719542-EDDE-4235-92FC-A3AAD30ECB45Q33365863-9FA93E72-DCB5-4E0D-A939-5C069CED00C0Q33398819-4FF99EB8-3D70-46FE-8CCC-4478CD595C4FQ33571858-30A18394-685F-427C-B68E-1E1C2D1F7BEEQ33797539-AC832192-801F-41E0-BD1B-F4DB496A84E5Q33974663-4F20614D-F094-466F-94C4-7ABA74BC0806Q34062290-8079733C-3ED8-432C-B5BE-97C51DB5DC6CQ34274829-9D16C6AF-A9A5-455E-9BD8-8A8C76078D9BQ34349235-9ADEFD8B-3346-469A-B430-78200B85D5CCQ34507164-DA8E6CB5-F6E4-4B83-8EA9-C260F6884D05Q34630074-B777040B-2FDB-4CE1-BC79-967BAAF8870DQ35291755-9C91BC35-EBD5-420B-8990-E85F8C120A83Q35583850-A3C618CF-D5C9-4CE2-9DBD-2E8AA91D7260Q35628022-3CC8EB39-2CE7-418E-865E-6E4853F93998Q35664565-08DBB550-EA04-4323-B9B0-E836BD47B4C6Q36389834-92762E61-C79A-4F24-85C2-3C40F4604223Q36429900-BABE79AF-6D99-4940-BE63-FF930C19F5D6Q37334515-E65546D6-5BE3-4458-AE79-FFB715482C2FQ37352062-4B690879-70B0-45D9-92B0-9632D99C4A11Q37641632-C3C98148-7933-4DB1-9466-09F6F9ABFDB8Q37853747-88AF95FB-1C2C-4C84-8F38-E2D853336DCCQ37981596-9E58B740-D826-443A-AC79-F819FCF3A272Q39403272-A4C99AF1-A4B1-455B-89CE-99F8206F97E3Q41931102-C9FD6920-DAE4-4673-8761-1A94EE23EACDQ43805056-D3B94FB7-A5C5-48E7-B40F-48CE15FBFA08Q44134906-78DEA8BB-EF07-430C-8551-18FCB8607D1FQ44357134-D7A64824-1F9B-4D0F-B775-08185EE16F13Q44490738-4FF54F30-CCA6-4A25-90EB-23C2EE5CF069
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jonathan Emberson
@ast
Jonathan Emberson
@en
Jonathan Emberson
@es
Jonathan Emberson
@nl
Jonathan Emberson
@sl
type
label
Jonathan Emberson
@ast
Jonathan Emberson
@en
Jonathan Emberson
@es
Jonathan Emberson
@nl
Jonathan Emberson
@sl
prefLabel
Jonathan Emberson
@ast
Jonathan Emberson
@en
Jonathan Emberson
@es
Jonathan Emberson
@nl
Jonathan Emberson
@sl
P214
P106
P1153
6701688192
P21
P214
P31
P496
0000-0001-7792-9422
P734
P735
P7859
viaf-313475947